3624 results for «582»

Filter By

3624 results

Mastering structural heart intervention with innovations in imaging

25 Nov 2024 – From PCR London Valves 2024

Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...

Mastering structural heart intervention with innovations in imaging

Align for the future with Myval THV series - From randomised trials to everyday clinical practice

25 Nov 2024 – From PCR London Valves 2024

Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...

Align for the future with novel balloon expandable Myval THV series

New frontiers in TAVI: have we reached them?

25 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.

New frontiers in TAVI: have we reached them?

Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation

25 Nov 2024 – From PCR London Valves 2024

This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...

Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation

Align for the future with the novel balloon expandable Myval transcatheter heart valve series

26 Nov 2024 – From PCR London Valves 2024

Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....

Align for the future

Unlocking the potential of mitral and tricuspid valves clipping

24 Nov 2024 – From PCR London Valves 2024

This session examines two compelling cases: a 78-year-old woman with paroxysmal atrial fibrillation, chest trauma, an osteoporotic sternum fracture, and NYHA II exertional dyspnoea, and an 82-year-old man with chronic three-vessel coronary artery disease, bradycardic AF, peripheral arterial disease, spinal stenosis, and chronic kidney disease. Through...

Unlocking the potential of mitral and tricuspid valves clipping

Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system

26 Nov 2024 – From PCR London Valves 2024

Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...

Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system

TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease

26 Nov 2024 – From PCR London Valves 2024

Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...

TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease

From index procedure to re-valving with a novel self-expanding valve

25 Nov 2024 – From PCR London Valves 2024

Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...

From index procedure to re-valving with a novel self-expanding valve

Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning

26 Nov 2024 – From PCR London Valves 2024

Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.

Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning

Pushing the boundaries to optimise patient outcomes: from planning to success

26 Nov 2024 – From PCR London Valves 2024

Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.

Pushing the boundaries to optimise patient outcomes: from planning to success

Zero-contrast TAVI while using a novel full-body embolic protection filter

26 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.

Zero-contrast TAVI while using a novel full-body embolic protection filter

A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution

26 Nov 2024 – From PCR London Valves 2024

Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.

A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution

Featured research - Aortic valve (Part 2)

24 Nov 2024 – From PCR London Valves 2024

This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.

Featured research - Aortic valve (Part 2)

Rapid-fire - TAVI

24 Nov 2024 – From PCR London Valves 2024

Dive into this rapid-fire session showcasing selected PCR London Valves 2024 Clinical Cases submissions related to TAVI. Explore diverse and challenging TAVI scenarios, including TAVI in patients with cardiogenic shock, pure aortic regurgitation, and patient-prosthesis mismatch. Gain insights into troubleshooting techniques and strategies for navigating complex...

Rapid-fire - TAVI

Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions

24 Nov 2024 – From PCR London Valves 2024

Electrosurgery and leaflet modification are revolutionizing transcatheter valve interventions, addressing unmet needs for patients who lack conventional treatment options. This video offers a deep dive into the clinical applications of these advanced techniques and equips you with the knowledge to implement them effectively.

You’ll discover:

  • How electrosurgical tools,...
Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions

Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice

24 Nov 2024 – From PCR London Valves 2024

Is early TAVI the right choice for your asymptomatic patients with severe aortic stenosis? In this video, we break down the latest clinical trials, including EARLY TAVR and EVOLVED, to help you navigate the complex decision-making process.

Find out what these studies really tell us about the...

Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice

TAVI innovations: late-breaking trials from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.

You’ll dive into the CANNULATE TAVR EXTENDED...

TAVI innovations: late-breaking trials from PCR London Valves 2024

Featured research - Tricuspid valve (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Explore the latest research on tricuspid valve interventions in this featured session from PCR London Valves 2024. Discover insights on the prognostic impact of heart failure hospitalization in severe tricuspid regurgitation, the influence of moderate mitral regurgitation in tricuspid TEER patients, the association of effective right...

Featured research - Tricuspid valve (Part 1)

Featured cases - Strategic approaches in mitral regurgitation

24 Nov 2024 – From PCR London Valves 2024

Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...

Featured cases - Strategic approaches in mitral regurgitation
Didn’t find what you were looking for?